A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (P05664 AM5)

This study has been terminated.

Sponsor:

Information provided by (Responsible Party):

Merck Sharp & Dohme Corp.

ClinicalTrials.gov Identifier:

NCT01155479

First received: June 30, 2010

Last updated: October 23, 2014

Last verified: October 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2013
Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)